BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1237137)

  • 1. Amantadine and apomorphine: interactions on striatal dopamine receptors.
    Cox B
    Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of bradykinin on central dopamine receptors.
    Przesmycki K; Kleinrok Z
    Pol J Pharmacol Pharm; 1976; 28(6):673-8. PubMed ID: 1034925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
    Randrup A; Mogilnicka E
    Pol J Pharmacol Pharm; 1976; 28(6):551-6. PubMed ID: 1034919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
    Kuschinsky K
    Psychopharmacologia; 1975 Jun; 42(3):225-9. PubMed ID: 1172252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
    Afanas'ev II; Dvorkina ML; RaevskiÄ­ KS
    Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
    Humber LG; Bruderlein FT; Voith K
    Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
    [No Abstract]   [Full Text] [Related]  

  • 12. The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol.
    Snyder SH; Creese I; Burt DR
    Psychopharmacol Commun; 1975; 1(6):663-73. PubMed ID: 1241457
    [No Abstract]   [Full Text] [Related]  

  • 13. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM; Lane JD; Brauchi JT
    Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester.
    Worms P; Scatton B
    Eur J Pharmacol; 1977 Oct; 45(4):395-6. PubMed ID: 562764
    [No Abstract]   [Full Text] [Related]  

  • 15. [Compounds stimulating central catecholamine receptors].
    Grabowska M
    Postepy Hig Med Dosw; 1973; 27(2):209-39. PubMed ID: 4787947
    [No Abstract]   [Full Text] [Related]  

  • 16. Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.
    Scatton B; Worms P
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):271-8. PubMed ID: 567284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esters of apomorphine and N,N-dimethyldopamine as agonists of dopamine receptors in the rat brain in vivo.
    Baldessarini RJ; Walton KG; Borgman RJ
    Neuropharmacology; 1975 Oct; 14(10):725-31. PubMed ID: 1238952
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine receptor sensitivity after repeated morphine administrations to rats.
    Kuschinsky K
    Life Sci; 1975 Jul; 17(1):43-8. PubMed ID: 167254
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of apomorphine, amantadine and dimethylaminoadamantane on the level of cyclic AMP in the rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1977; 29(2):93-9. PubMed ID: 193093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.